Our primary beneficiary is the Brain Tumor Trials Collaborative (BTTC), a group of highly respected and dedicated doctors in a network of renowned medical centers. Led by MD Anderson Cancer Center, the BTTC has grown to more than 15 member institutions and has experienced unparalleled advancements in the research of alternative treatments of malignant brain tumors. Research studies, also known as clinical trials, are being conducted to learn of promising advances to cancer prevention, diagnosis and treatments that are safe and effective.

Funds raised through the Head for the Cure Foundation provided the seed money to help launch the BTTC. And Head For the Cure remains committed to supporting the BTTC and its mission with ongoing financial support.